How agentic AI is rewriting pharma’s commercial playbook
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
How agentic AI is rewriting pharma’s commercial playbook
Biomarkers are shaping Parkinson’s diagnosis and trials
Supporting the vet workforce is vital to the future of public health
Another unforgettable Clinical Researcher of the Year Awards
Decoding Parkinson’s disease with AI and the cloud
Why appreciating representative trial participation matters
Coming out of the dark – a new decade for the NHS?
Pharma’s $100bn+ opportunity to redefine obesity treatment